These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14563694)

  • 1. Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium-insensitive phospholipase A2 gene expression.
    Lawrence KM; Scarabelli TM; Turtle L; Chanalaris A; Townsend PA; Carroll CJ; Hubank M; Stephanou A; Knight RA; Latchman DS
    FASEB J; 2003 Dec; 17(15):2313-5. PubMed ID: 14563694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage.
    Lawrence KM; Townsend PA; Davidson SM; Carroll CJ; Eaton S; Hubank M; Knight RA; Stephanou A; Latchman DS
    Biochem Biophys Res Commun; 2004 Aug; 321(2):479-86. PubMed ID: 15358201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.
    Sargent CA; Wilde MW; Dzwonczyk S; Tuttle JG; Murray HN; Atwal K; Grover GJ
    Cardiovasc Res; 1996 Feb; 31(2):270-7. PubMed ID: 8730404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective activity of urocortin by preventing caspase-independent, non-apoptotic death in cultured neonatal rat cardiomyocytes exposed to ischemia.
    Takatani-Nakase T; Takahashi K
    Biochem Biophys Res Commun; 2010 Nov; 402(2):216-21. PubMed ID: 20933497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
    Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS
    FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes.
    Gordon JM; Dusting GJ; Woodman OL; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H330-6. PubMed ID: 12388260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K(ATP) channel gene expression is induced by urocortin and mediates its cardioprotective effect.
    Lawrence KM; Chanalaris A; Scarabelli T; Hubank M; Pasini E; Townsend PA; Comini L; Ferrari R; Tinker A; Stephanou A; Knight RA; Latchman DS
    Circulation; 2002 Sep; 106(12):1556-62. PubMed ID: 12234964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A calcium-independent phospholipase activity insensitive to bromoenol lactone mediates arachidonic acid release by lindane in rat myometrial cells.
    Wang CT; Peters-Golden M; Loch-Caruso R
    Life Sci; 2001 Dec; 70(4):453-70. PubMed ID: 11798014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.
    Xie Z; Gong MC; Su W; Turk J; Guo Z
    J Biol Chem; 2007 Aug; 282(35):25278-89. PubMed ID: 17613534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells.
    Ramanadham S; Hsu FF; Bohrer A; Ma Z; Turk J
    J Biol Chem; 1999 May; 274(20):13915-27. PubMed ID: 10318801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2.
    Strokin M; Chechneva O; Reymann KG; Reiser G
    Neuroscience; 2006 Jun; 140(2):547-53. PubMed ID: 16563639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes.
    Kan H; Xie Z; Finkel MS
    J Mol Cell Cardiol; 2006 Jan; 40(1):131-7. PubMed ID: 16316660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability.
    Forlenza OV; Mendes CT; Marie SK; Gattaz WF
    Prostaglandins Leukot Essent Fatty Acids; 2007 Jan; 76(1):47-55. PubMed ID: 17187973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin increases the expression of heat shock protein 90 in rat cardiac myocytes in a MEK1/2-dependent manner.
    Brar BK; Railson J; Stephanou A; Knight RA; Latchman DS
    J Endocrinol; 2002 Feb; 172(2):283-93. PubMed ID: 11834446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury.
    Valentim L; Laurence KM; Townsend PA; Carroll CJ; Soond S; Scarabelli TM; Knight RA; Latchman DS; Stephanou A
    J Mol Cell Cardiol; 2006 Jun; 40(6):846-52. PubMed ID: 16697404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission.
    St-Gelais F; Ménard C; Congar P; Trudeau LE; Massicotte G
    Hippocampus; 2004; 14(3):319-25. PubMed ID: 15132431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection.
    Yuan Z; McCauley R; Chen-Scarabelli C; Abounit K; Stephanou A; Barry SP; Knight R; Saravolatz SF; Saravolatz LD; Ulgen BO; Scarabelli GM; Faggian G; Mazzucco A; Saravolatz L; Scarabelli TM
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):1-7. PubMed ID: 20416357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective action of urocortin in early pre- and postconditioning.
    Cserepes B; Jancsó G; Gasz B; Rácz B; Ferenc A; Benkó L; Borsiczky B; Kürthy M; Ferencz S; Lantos J; Gál J; Arató E; Miseta A; Wéber G; Róth E
    Ann N Y Acad Sci; 2007 Jan; 1095():228-39. PubMed ID: 17404036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromoenol lactone, an inhibitor of Group V1A calcium-independent phospholipase A2 inhibits antigen-stimulated mast cell exocytosis without blocking Ca2+ influx.
    Fensome-Green A; Stannard N; Li M; Bolsover S; Cockcroft S
    Cell Calcium; 2007 Feb; 41(2):145-53. PubMed ID: 16854462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.